Related references
Note: Only part of the references are listed.Levetiracetam prophylaxis in pediatric migraine - An open-label study
Ann Pakalnis et al.
HEADACHE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Levetiracetam in the prophylaxis of migraine with aura: A 6-month open-label study
Filippo Brighina et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Zonisamide for migraine prophylaxis in refractory patients
A. Ashkenazi et al.
CEPHALALGIA (2006)
Brain gray matter changes in migraine patients with T2-visible lesions - A 3-T MRI study
Maria A. Rocca et al.
STROKE (2006)
Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine
Alan Rapoport et al.
HEADACHE (2006)
Migraine prevention: What patients want from medication and their physicians (a headache specialty clinic perspective)
TD Rozen
HEADACHE (2006)
The impact of migraine on daily activities: effect of topiramate compared with placebo
Stephen D. Silberstein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials
G Bussone et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Comorbidity of migraine
AI Scher et al.
CURRENT OPINION IN NEUROLOGY (2005)
Practical use of topiramate for migraine prevention
JL Brandes
HEADACHE (2005)
General principles of migraine management: The changing role of prevention
E Loder et al.
HEADACHE (2005)
Interictal daily functioning in migraine
DL Stronks et al.
CEPHALALGIA (2004)
Topiramate in migraine prevention - Results of a large controlled trial
SD Silberstein et al.
ARCHIVES OF NEUROLOGY (2004)
Efficacy and safety of levetiracetam in pediatric migraine
GS Miller
HEADACHE (2004)
Topiramate for migraine prevention - A randomized controlled trial
JL Brandes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Consecutive Transcranial magnetic stimulation: Phosphene thresholds in migraineurs and controls
WB Young et al.
HEADACHE (2004)
Migraine as a risk factor for subclinical brain lesions
MC Kruit et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control
HC Diener et al.
JOURNAL OF NEUROLOGY (2004)
Toward better characterization of the migraine patient: Complex migraine comorbidity disorder
RS Singer
HEADACHE (2004)
When can successful migraine prophylaxis be discontinued?
RW Evans et al.
HEADACHE (2004)
Open-label zonisamide for refractory migraine
ME Drake et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Stress, anxiety, depression and migraine
C Wacogne et al.
CEPHALALGIA (2003)
Factors associated with the onset and remission of chronic daily headache in a population-based study
AI Scher et al.
PAIN (2003)
Usefulness of the SF-8 (TM) Health Survey for comparing the impact of migraine and other conditions
DM Turner-Bowker et al.
QUALITY OF LIFE RESEARCH (2003)
Pharmacologic management of acute attacks of migraine and prevention of migraine headache
V Snow et al.
ANNALS OF INTERNAL MEDICINE (2002)
Migraine and psychiatric comorbidity: From theory and hypotheses to clinical application
FD Sheftell et al.
HEADACHE (2002)
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis
FG Freitag et al.
NEUROLOGY (2002)
Giving voice to the lifeworld. More humane, more effective medical care? A qualitative study of doctor-patient communication in general practice
CA Barry et al.
SOCIAL SCIENCE & MEDICINE (2001)
Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness?
KMA Welch et al.
HEADACHE (2001)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Efficacy of gabapentin in migraine prophylaxis
NT Mathew et al.
HEADACHE (2001)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
The impact of migraine on quality of life in the general population - The GEM study
GM Terwindt et al.
NEUROLOGY (2000)
Patients' unvoiced agendas in general practice consultations: qualitative study
CA Barry et al.
BRITISH MEDICAL JOURNAL (2000)